Cv2.1169

N/A

Report date: 2025/05/21 14:48:51

Base Information

Drug NameCv2.1169
Drug Alias NameCv2.1169Cv2-1169Cv-2-1169
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitut Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesInstitut Pasteur
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A